CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common stock	Paid-in capital	Retained earnings	Non controlling interest	Accum other comp loss	Series A preferred stock	Series B preferred stock
Beginning Balance at Dec. 31, 2019	$ 344,948	$ 174	$ 157,886	$ 205,680	$ 1,146	$ (19,954)	$ 1	$ 15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(23)			(23)
Compensation expense for restricted stock	904		904
Tax related items for share based awards	(94)		(94)
Issuance of shares of common stock	2,000	1	1,999
Currency translation adjustment	(1,163)					(1,163)
Net income	5,648			5,710	(62)
Ending Balance at Mar. 31, 2020	352,220	175	160,695	211,367	1,084	(21,117)	1	15
Beginning Balance at Dec. 31, 2020	347,866	189	192,068	176,637	798	(21,842)	1	15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred dividends paid	(23)			(23)
Compensation expense for restricted stock	380		380
Tax related items for share based awards	(517)		(517)
Currency translation adjustment	5,106			0		5,106
Net income	128			340	(212)
Ending Balance at Mar. 31, 2021	$ 352,940	$ 189	$ 191,931	$ 176,954	$ 586	$ (16,736)	$ 1	$ 15